Neurodevelopmental disorders and anti-epileptic treatment in a patient with a SATB1 mutation: A case report

Area of Science:

• Genetics
• Neurodevelopmental Disorders
• Pharmacology

Background:

• Germline variations in the SATB1 gene are associated with developmental delay, dysmorphic facies, and dental anomalies.
• Epilepsy is a common clinical feature in SATB1-related neurodevelopmental disorders, but effective treatments remain largely unknown.

Observation:

• A Chinese patient with mild developmental delay was identified with a de novo truncating variation in the SATB1 gene.
• The patient presented with epilepsy, a hallmark symptom of SATB1-related neurodevelopmental disorders.

Findings:

• A detailed anti-epileptic pharmacological treatment regimen was administered to the patient.
• The implemented treatment strategy resulted in a favorable clinical outcome for the patient's epilepsy.

Implications:

• This case provides crucial information for the prognosis and treatment of rare neurological developmental disorders caused by SATB1 gene mutations.
• The study highlights the importance of targeted anti-epileptic treatment in managing SATB1-related neurodevelopmental disorders.
• Findings may guide clinicians in managing similar rare genetic conditions affecting neurodevelopment and epilepsy.